Trial registration number
|
ISRCTN10942585 |
Full text link
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
https://www.isrctn.com/ISRCTN10942585
|
First author
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Monika Klírová
|
Contact
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
monika.klirova@nudz.cz
|
Registration date
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2022-05-06
|
Recruitment status
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Recruiting
|
Study design
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
RCT
|
Allocation
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Randomized
|
Design
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Parallel
|
Masking
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Blind label
|
Center
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
single-center
|
Study aim
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Long covid
|
Inclusion criteria
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
1. Male and female outpatients aged 18-75 years with a history of COVID-19 and monitored by an outpatient physician for mental disorders (anxiety, mood disorders, sleep) within the PASC 2. PCR RNA SARS-CoV-2 negativity at screening/study entry 3. Duration of symptoms >1 and =18 months after detection of COVID-19 4. The mental ability to understand and sign the Informed Consent Form 5. Presence of neuropsychiatric PASC symptoms as determined by A-PASC with a minimum overall score =25 (cognitive score, emotional and functional impairment) 6. FIS questionnaire score =40 7. Psychopharmacological medication (if used) at a stable dose =4 weeks.
|
Exclusion criteria
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
1. Contraindications of tDCS (skin disease, superficial injury, and fracture or infraction of skull in the stimulation area, epilepsy, metallic plates in the head) 2. History of any other DSM-IV axis I diagnosis prior to COVID-19, except for: 2.1. Depressive disorders, anxiety disorders, and sleep disorders that may be present in the history, but with at least 6 months of documented remission of symptoms 2.2. Disorders associated with the use of addictive substances at least 6 months before entering the study 3. Pregnancy or breastfeeding 4. Patients with severe and/or unstable somatic disorders (cardiovascular disease, neoplasms, endocrinology disorders, etc) 5. Patients suffering from a serious neurological disorder (eg epilepsy, head injury with loss of consciousness)
|
Number of arms
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2
|
Funding
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Czech Health Research Council
|
Inclusion age min
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
18
|
Inclusion age max
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
75
|
Countries
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Czech Republic
|
Type of patients
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Patients recovered from covid
|
Severity scale
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
N/A
|
Total sample size
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
34
|
primary outcome
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Czech version of the “Fatigue Impact Scale“ (FIS) score after the acute phase of the study and after the 4W-FU
|
Notes
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
|
Phase
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not reported
|
Arms
Last imported at : May 12, 2022, 1:30 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "", "treatment_id": 2484, "treatment_name": "Anodal tdcs", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|